| Value | ₹0.20 Cr |
|---|
NSE filing, NSE: INDOCO. Summary written from the filing by ALFA Finder's alert engine.
Indoco Remedies Ltd: key numbers
- Share price
- ₹215.06
- Market cap
- ₹1,985 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 62.2×Sector 43.0×
- Promoter holding
- 58.92%+0.06% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indoco Remedies Ltd
All →Indoco Remedies Promoter Buying: ₹0.13 Cr
Indoco Remedies promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 5,996 equity shares via market purchase. The total transaction value is ₹0.13 Crore.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.01%
Indoco Remedies Promoter Buying: ₹0.17 Cr
Indoco Remedies' promoters Aditi Panandikar and Madhura Suresh Kare acquired 8,004 shares via market purchase. The total transaction value is ₹0.17 Crore.
- Value
- ₹0.17 Cr
Indoco Remedies Earnings Call Transcript: Key Takeaways
Indoco Remedies hit record quarterly revenue exceeding ₹500 Cr, but faced margin compression from elevated geopolitical freight and material costs.
- Call
- Guides 10% growth
Indoco Remedies Business Update
Indoco's CRO AnaCipher received ANVISA Brazil approval for clinical and bioanalytical facilities. This expands its regulatory footprint to conduct bioequivalence studies in Brazil and Latin America.
Indoco Remedies Q2 FY27 Results: Turns Profitable, Net Profit ₹19.5 Cr
Indoco Remedies Ltd reported revenue from operations of ₹506.9 Cr (+7.4% YoY) and net profit of ₹19.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹19.5 Cr
Indoco Remedies Employee Stock Options
Indoco Remedies allotted 14,850 ESOP shares to its Employees Welfare Trust under the 2022 ESOP plan. The allotment is at face value with no transaction price.
Other financial results announcements
All →GRE Renew Enertech H1 FY27 Results: Net Profit ₹9.1 Cr, Up 127.5% YoY
GRE Renew Enertech Ltd reported revenue from operations of ₹138.7 Cr (+216.7% YoY) and net profit of ₹9.1 Cr (+127.5% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.1 Cr · +127.5% YoY
Kenrik Industries H1 FY27 Results: Net Profit ₹0 Cr
Kenrik Industries filed unaudited half-year results to September 2026, with a limited review report. Profit was negligible and revenue declined from the prior-year half.
- Key figure
- Net profit ₹0 Cr
Blue Water Logistics Q2 FY27 Results: Net Profit ₹16 Cr, Up 213.7% YoY
Blue Water Logistics Ltd reported revenue from operations of ₹272.1 Cr (+211.3% YoY) and net profit of ₹16 Cr (+213.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹16 Cr · +213.7% YoY
Vinit Mobile H1 FY27 Results: Net Profit ₹2.9 Cr, Down 14.7% YoY
Vinit Mobile Ltd reported revenue from operations of ₹46 Cr (+14.7% YoY) and net profit of ₹2.9 Cr (-14.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.9 Cr · -14.7% YoY
Ramky Infrastructure Q2 FY27 Results: Net Profit ₹102.8 Cr, Up 36.0% YoY
Ramky Infrastructure Ltd reported revenue from operations of ₹604.5 Cr (+28.2% YoY) and net profit of ₹102.8 Cr (+36.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹102.8 Cr · +36.0% YoY
Kilitch Drugs(I) Q2 FY27 Results: Net Profit ₹1.4 Cr, Down 82.5% YoY
Kilitch Drugs(I) Ltd reported revenue from operations of ₹50.2 Cr (+2.7% YoY) and net profit of ₹1.4 Cr (-82.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.4 Cr · -82.5% YoY